Chara Stavraka

12PUBLICATIONS
52CO-AUTHORS
Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 10, 2025
Hyperinflammatory repolarisation of ovarian cancer patient macrophages by anti-tumour IgE antibody, MOv18, restricts an immunosuppressive macrophage:Treg cell interaction.

Gabriel Osborn, Jacobo López-Abente, Rebecca Adams

|Mar 06, 2025
Non-Allergic Urticarial Skin Reactions Associated With MOv18 IgE, a First-In-Class IgE Antibody Recognising Folate Receptor Alpha.

Chara Stavraka, Jitesh Chauhan, Silvia Crescioli

|May 15, 2023
Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4.

Jitesh Chauhan, Melanie Grandits, Lais C G F Palhares

|Dec 23, 2022
Non-Small Cell Lung Cancer (NSCLC) in Young Adults, Age < 50, Is Associated with Late Stage at Presentation and a Very Poor Prognosis in Patients That Do Not Have a Targeted Therapy Option: A Real-World Study

Daniel Johnathan Hughes, Matthaios Kapiris, Andreja Podvez Nevajda

|Nov 19, 2022
Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes.

Heather J Bax, Jitesh Chauhan, Chara Stavraka

|Jan 12, 2022
Macrophages in ovarian cancer and their interactions with monoclonal antibody therapies.

Gabriel Osborn, Chara Stavraka, Rebecca Adams

Pageof 2

Frequent Collaborators

7 joint publications

Sophia N Karagiannis

6 joint publications

Heather J Bax

3 joint publications

James Spicer

3 joint publications

Rebecca Kristeleit